BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID
146 results:

  • 1. Regulatory T cells expressing CD19-targeted chimeric antigen receptor restore homeostasis in Systemic Lupus Erythematosus.
    Doglio M; Ugolini A; Bercher-Brayer C; Camisa B; Toma C; Norata R; Del Rosso S; Greco R; Ciceri F; Sanvito F; Casucci M; Manfredi AA; Bonini C
    Nat Commun; 2024 Mar; 15(1):2542. PubMed ID: 38538608
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Association of Immune Cell Infiltration with Metastasis Location in De Novo Metastatic Triple Negative Breast cancer: A Multicenter Cross-Sectional Study in Indonesia.
    Tenggara JB; Rachman A; Prihartono J; Lisnawati L; Panigoro SS; Heriyanto DS; Steven R; Tandarto K; Juanputra S; Sudoyo AW
    Acta Med Indones; 2023 Oct; 55(4):376-384. PubMed ID: 38213050
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostic value and distribution pattern of tumor infiltrating lymphocytes and their subsets in distant metastases of advanced breast cancer.
    Sun XY; Wang CQ; Mao Y; Zhang ZQ; Cui J; Dong XN; Wang HB
    Clin Breast Cancer; 2024 Apr; 24(3):e167-e176. PubMed ID: 38212189
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Features of the TCR repertoire associate with patients' clinical and molecular characteristics in acute myeloid leukemia.
    Pospiech M; Tamizharasan M; Wei YC; Kumar AMS; Lou M; Milstein J; Alachkar H
    Front Immunol; 2023; 14():1236514. PubMed ID: 37928542
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Dynamic Responses of Circulating T Cells After Stereotactic Body Radiation Therapy for bone Metastasis in Patients With Breast cancer.
    Jeon SH; Jang BS; Kim DY; Kim JH; Shin EC; Kim IA
    Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):790-800. PubMed ID: 37802227
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. E-cadherin expression in the tumor microenvironment of advanced epidermal growth factor receptor-mutant lung adenocarcinoma and the association with prognosis.
    Chang YP; Huang GK; Chen YC; Huang KT; Chen YM; Lin CY; Huang CC; Lin MC; Wang CC
    BMC Cancer; 2023 Jun; 23(1):569. PubMed ID: 37340370
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. NLRP3 Disturbs Treg/Th17 Cell Balance to Aggravate Apical Periodontitis.
    Leng S; Xu W; Wu L; Liu L; Du J; Yang F; Huang D; Zhang L
    J Dent Res; 2023 Jun; 102(6):656-666. PubMed ID: 36883625
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease.
    Penter L; Liu Y; Wolff JO; Yang L; Taing L; Jhaveri A; Southard J; Patel M; Cullen NM; Pfaff KL; Cieri N; Oliveira G; Kim-Schulze S; Ranasinghe S; Leonard R; Robertson T; Morgan EA; Chen HX; Song MH; Thurin M; Li S; Rodig SJ; Cibulskis C; Gabriel S; Bachireddy P; Ritz J; Streicher H; Neuberg DS; Hodi FS; Davids MS; Gnjatic S; Livak KJ; Altreuter J; Michor F; Soiffer RJ; Garcia JS; Wu CJ
    Blood; 2023 Apr; 141(15):1817-1830. PubMed ID: 36706355
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Assessment of regulatory T cells (Tregs) and foxp3 methylation level in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy.
    Sabir SF; Matti BF; Alwatar WMA
    Immunogenetics; 2023 Apr; 75(2):145-153. PubMed ID: 36567345
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Tumor Growth Rate in Spinal Giant Cell Tumors of bone and Association With the Immune Microenvironment and Denosumab Treatment Responsiveness: A Multicenter Study.
    Zheng BW; Zheng BY; Niu HQ; Yang YF; Zhu GQ; Li J; Zhang TL; Zou MX
    Neurosurgery; 2023 Mar; 92(3):524-537. PubMed ID: 36409294
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Characterization of the tumour microenvironment phenotypes in malignant tissues and pleural effusion from advanced osteoblastic osteosarcoma patients.
    Zhang Z; Ji W; Huang J; Zhang Y; Zhou Y; Zhang J; Dong Y; Yuan T; Yang Q; Ding X; Tang L; Li H; Yin J; Wang Y; Ji T; Fei J; Zhang B; Chen P; Hu H
    Clin Transl Med; 2022 Nov; 12(11):e1072. PubMed ID: 36305631
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. cancer co-opts differentiation of B-cell precursors into macrophage-like cells.
    Chen C; Park B; Ragonnaud E; Bodogai M; Wang X; Zong L; Lee JM; Beerman I; Biragyn A
    Nat Commun; 2022 Sep; 13(1):5376. PubMed ID: 36104343
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Immunosuppressive Effects and Potent Anti-tumor Efficacy of mTOR Inhibitor Everolimus in Breast Tumor-bearing Mice.
    Rostamzadeh D; Haghshenas MR; Samadi M; Mojtahedi Z; Babaloo Z; Ghaderi A
    Iran J Allergy Asthma Immunol; 2022 Jun; 21(3):287-299. PubMed ID: 35822679
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Immune contexture of paediatric cancers.
    Thakur MD; Franz CJ; Brennan L; Brouwer-Visser J; Tam R; Korski K; Koeppen H; Ziai J; Babitzki G; Ranchere-Vince D; Vasiljevic A; Dijoud F; Marec-Bérard P; Rochet I; Cannarile MA; Marabelle A
    Eur J Cancer; 2022 Jul; 170():179-193. PubMed ID: 35660252
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. IL-33 acts as a costimulatory signal to generate alloreactive Th1 cells in graft-versus-host disease.
    Dwyer GK; Mathews LR; Villegas JA; Lucas A; Gonzalez de Peredo A; Blazar BR; Girard JP; Poholek AC; Luther SA; Shlomchik W; Turnquist HR
    J Clin Invest; 2022 Jun; 132(12):. PubMed ID: 35503257
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Synergistic effect of Abraxane that combines human IL15 fused with an albumin-binding domain on murine models of pancreatic ductal adenocarcinoma.
    Hsu FT; Tsai CL; Chiang IT; Lan KH; Yueh PF; Liang WY; Lin CS; Chao Y; Lan KL
    J Cell Mol Med; 2022 Apr; 26(7):1955-1968. PubMed ID: 35174623
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Combination therapy with Nab-paclitaxel and the interleukin-15 fused with anti-human serum albumin nanobody as a synergistic treatment for colorectal cancer.
    Wu L; Wang W; Tian J; Qi C; Cai Z; Yan W; Xuan S; Shang A
    Bioengineered; 2022 Jan; 13(1):1942-1951. PubMed ID: 35019820
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. CML derived exosomes promote tumor favorable functional performance in T cells.
    Jafarzadeh N; Gholampour MA; Alivand MR; Kavousi S; Arzi L; Rad F; Sadeghizadeh M; Pornour M
    BMC Cancer; 2021 Sep; 21(1):1002. PubMed ID: 34493241
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Secretome screening reveals immunomodulating functions of IFNα-7, PAP and GDF-7 on regulatory T-cells.
    Ding M; Malhotra R; Ottosson T; Lundqvist M; Mebrahtu A; Brengdahl J; Gehrmann U; Bäck E; Ross-Thriepland D; Isaksson I; Magnusson B; Sachsenmeier KF; Tegel H; Hober S; Uhlén M; Mayr LM; Davies R; Rockberg J; Schiavone LH
    Sci Rep; 2021 Aug; 11(1):16767. PubMed ID: 34408239
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Tumor microenvironment in giant cell tumor of bone: evaluation of PD-L1 expression and SIRPα infiltration after denosumab treatment.
    Toda Y; Kohashi K; Yamamoto H; Ishihara S; Ito Y; Susuki Y; Kawaguchi K; Kiyozawa D; Takamatsu D; Kinoshita I; Yamada Y; Maehara J; Kimura A; Tamiya S; Taguchi K; Matsunobu T; Matsumoto Y; Nakashima Y; Mawatari M; Oda Y
    Sci Rep; 2021 Jul; 11(1):14821. PubMed ID: 34285260
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.